Science Explorer Interactive view Map
Company · Basel · Switzerland

PIQUR Therapeutics (Switzerland)

piqur.comROR OpenAlex
Research works
35
▼ 23% vs 2013–17
Citations
1.6k
43.8 per fractional work
Top-10% rate
14.2%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: PIQUR Therapeutics (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.67× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.64× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 10.56× its world share, 1 worksImmunology and Micro…Neuroscience: 1.44× its world share, 0 worksNeuroscienceChemistry: 1.01× its world share, 0 worksChemistryEngineering: 0.37× its world share, 0 worksEngineeringMedicine: 2.42× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.6×. Every wedge is a field page.

Which keywords describe research at PIQUR Therapeutics (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Metabolism, Signaling, mTOR, PI3K/AKT pathway, Cancer Therapy, Metastatic Breast Cancer and Synthesis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Cancer8▲ 15×16 topics
  2. Metabolism6▲ 28×3 topics
  3. Signaling6▲ 153×3 topics
  4. PI3K/AKT pathway6▲ 794×1 topic
  5. mTOR6▲ 794×1 topic
  6. Cancer Therapy3▲ 14×10 topics
  7. Metastatic Breast Cancer2▲ 90×2 topics
  8. Synthesis2▲ 9.6×7 topics
  9. Public Health2▲ 3.6×5 topics
  10. Quality of Life2▲ 3.6×2 topics
  11. Medicinal Chemistry2▲ 12×4 topics
  12. Anticancer Agents2▲ 17×4 topics
  13. Ethical Considerations2▲ 13×2 topics
  14. Transcriptional Regulation2▲ 16×4 topics
  15. Anticancer1▲ 21×5 topics
  16. Drug Discovery1▲ 9.6×5 topics
  17. Prognostic Factors1▲ 8.6×4 topics
  18. Targeted Therapy1▲ 19×3 topics
  19. Apoptosis1▲ 9.1×7 topics
  20. Antimicrobial1▲ 13×3 topics
  21. Cell Cycle Control1▲ 135×2 topics
  22. Cell Signaling1▲ 9.8×5 topics
  23. Chemotherapy-Induced Peripheral Neuropathy1▲ 67×1 topic
  24. Taxanes1▲ 67×1 topic
  25. ALK Inhibitors1▲ 58×1 topic
  26. Biological Evaluation1▲ 25×3 topics
  27. Clinical Trials1▲ 5.2×2 topics
  28. Drug Development1▲ 21×2 topics
  29. EGFR Mutations1▲ 58×1 topic
  30. Immune Response1▲ 5.0×4 topics
  31. Signal Transduction1▲ 12×2 topics
  32. BET Bromodomains1▲ 142×1 topic
  33. Biomedical Science1▲ 134×1 topic
  34. Health Research1▲ 45×1 topic
  35. Heterocyclic Compounds1▲ 18×2 topics
  36. PROTACs1▲ 142×1 topic
  37. Rituximab1▲ 18×2 topics

Which research topics does PIQUR Therapeutics (Switzerland) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, RNA Interference and Gene Delivery, Hematopoietic Stem Cell Transplantation and 3D Printing in Biomedical Research.

Lung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksHematopoietic Stem Cell …0Hematopoietic Stem Cell Transplantation: 0 fractional works3D Printing in Biomedica…03D Printing in Biomedical Research: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksRNA modifications and cancer: 0 fractional worksAnimal Disease Managemen…0Animal Disease Management and Epidemiology: 0 fractional worksHerpesvirus Infections a…0Herpesvirus Infections and Treatments: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksToxoplasma gondii Resear…0Toxoplasma gondii Research Studies: 0 fractional works
Pulmonary and Respiratory MedicineMolecular BiologyHematologyBiomedical Engineering4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 0 works
  3. 3 Hematopoietic Stem Cell Transplantation Hematology 0 works
  4. 4 3D Printing in Biomedical Research Biomedical Engineering 0 works
  5. 5 Cancer-related Molecular Pathways Oncology 0 works
  6. 6 RNA modifications and cancer Molecular Biology 0 works
  7. 7 Animal Disease Management and Epidemiology Agronomy and Crop Science 0 works
  8. 8 Herpesvirus Infections and Treatments Epidemiology 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Toxoplasma gondii Research Studies Parasitology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.7%not open64.3%

World: 28% of research is openly available.

with international co-authors43.5%domestic only56.5%

World: 19% is written across borders.

How has PIQUR Therapeutics (Switzerland)'s research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Basel

All research institutions in Basel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.